vs
Side-by-side financial comparison of Clear Channel Outdoor Holdings, Inc. (CCO) and Bio-Techne (TECH). Click either name above to swap in a different company.
Clear Channel Outdoor Holdings, Inc. is the larger business by last-quarter revenue ($461.5M vs $295.9M, roughly 1.6× Bio-Techne). Bio-Techne runs the higher net margin — 12.8% vs 1.7%, a 11.1% gap on every dollar of revenue. On growth, Clear Channel Outdoor Holdings, Inc. posted the faster year-over-year revenue change (8.2% vs -6.4%). Over the past eight quarters, Clear Channel Outdoor Holdings, Inc.'s revenue compounded faster (18.8% CAGR vs 4.2%).
Clear Channel Outdoor Holdings, Inc. is a multinational corporation focused on outdoor advertising. The company is based in San Antonio, Texas.
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
CCO vs TECH — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $461.5M | $295.9M |
| Net Profit | $8.0M | $38.0M |
| Gross Margin | — | 64.6% |
| Operating Margin | 23.3% | 18.4% |
| Net Margin | 1.7% | 12.8% |
| Revenue YoY | 8.2% | -6.4% |
| Net Profit YoY | 144.8% | 68.3% |
| EPS (diluted) | $0.01 | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $461.5M | $295.9M | ||
| Q3 25 | $405.6M | — | ||
| Q2 25 | $402.8M | $317.0M | ||
| Q1 25 | $334.2M | $316.2M | ||
| Q4 24 | $426.7M | $297.0M | ||
| Q3 24 | $375.2M | $289.5M | ||
| Q2 24 | $376.5M | $306.1M | ||
| Q1 24 | $326.8M | $303.4M |
| Q4 25 | $8.0M | $38.0M | ||
| Q3 25 | $-60.1M | — | ||
| Q2 25 | $9.5M | $-17.7M | ||
| Q1 25 | $62.5M | $22.6M | ||
| Q4 24 | $-17.9M | $34.9M | ||
| Q3 24 | $-32.5M | $33.6M | ||
| Q2 24 | $-39.2M | $40.6M | ||
| Q1 24 | $-89.7M | $49.1M |
| Q4 25 | — | 64.6% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 62.7% | ||
| Q1 25 | — | 67.9% | ||
| Q4 24 | — | 65.3% | ||
| Q3 24 | — | 63.2% | ||
| Q2 24 | — | 66.4% | ||
| Q1 24 | — | 67.4% |
| Q4 25 | 23.3% | 18.4% | ||
| Q3 25 | 19.9% | — | ||
| Q2 25 | 19.2% | -7.5% | ||
| Q1 25 | 13.5% | 12.2% | ||
| Q4 24 | 23.5% | 16.0% | ||
| Q3 24 | 17.8% | 13.8% | ||
| Q2 24 | 18.2% | 15.0% | ||
| Q1 24 | 13.4% | 22.1% |
| Q4 25 | 1.7% | 12.8% | ||
| Q3 25 | -14.8% | — | ||
| Q2 25 | 2.4% | -5.6% | ||
| Q1 25 | 18.7% | 7.1% | ||
| Q4 24 | -4.2% | 11.7% | ||
| Q3 24 | -8.7% | 11.6% | ||
| Q2 24 | -10.4% | 13.3% | ||
| Q1 24 | -27.4% | 16.2% |
| Q4 25 | $0.01 | $0.24 | ||
| Q3 25 | $-0.12 | — | ||
| Q2 25 | $0.02 | $-0.11 | ||
| Q1 25 | $0.13 | $0.14 | ||
| Q4 24 | $-0.03 | $0.22 | ||
| Q3 24 | $-0.07 | $0.21 | ||
| Q2 24 | $-0.08 | $0.26 | ||
| Q1 24 | $-0.19 | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $190.0M | $172.9M |
| Total DebtLower is stronger | $5.1B | $260.0M |
| Stockholders' EquityBook value | $-3.4B | $2.0B |
| Total Assets | $3.8B | $2.5B |
| Debt / EquityLower = less leverage | — | 0.13× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $190.0M | $172.9M | ||
| Q3 25 | $155.0M | — | ||
| Q2 25 | $138.6M | $162.2M | ||
| Q1 25 | $395.8M | $140.7M | ||
| Q4 24 | $109.7M | $177.5M | ||
| Q3 24 | $201.1M | $187.5M | ||
| Q2 24 | $189.3M | $152.9M | ||
| Q1 24 | $193.2M | $145.3M |
| Q4 25 | $5.1B | $260.0M | ||
| Q3 25 | $5.1B | — | ||
| Q2 25 | $5.1B | $346.0M | ||
| Q1 25 | $5.3B | $330.0M | ||
| Q4 24 | $5.7B | $300.0M | ||
| Q3 24 | $5.7B | $300.0M | ||
| Q2 24 | $5.7B | $319.0M | ||
| Q1 24 | $5.7B | $389.0M |
| Q4 25 | $-3.4B | $2.0B | ||
| Q3 25 | $-3.5B | — | ||
| Q2 25 | $-3.4B | $1.9B | ||
| Q1 25 | $-3.4B | $2.0B | ||
| Q4 24 | $-3.6B | $2.1B | ||
| Q3 24 | $-3.6B | $2.1B | ||
| Q2 24 | $-3.6B | $2.1B | ||
| Q1 24 | $-3.5B | $2.0B |
| Q4 25 | $3.8B | $2.5B | ||
| Q3 25 | $3.8B | — | ||
| Q2 25 | $3.8B | $2.6B | ||
| Q1 25 | $4.0B | $2.6B | ||
| Q4 24 | $4.8B | $2.7B | ||
| Q3 24 | $4.6B | $2.7B | ||
| Q2 24 | $4.5B | $2.7B | ||
| Q1 24 | $4.6B | $2.7B |
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.18× | ||
| Q1 25 | — | 0.16× | ||
| Q4 24 | — | 0.14× | ||
| Q3 24 | — | 0.14× | ||
| Q2 24 | — | 0.15× | ||
| Q1 24 | — | 0.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $56.3M | — |
| Free Cash FlowOCF − Capex | $30.3M | — |
| FCF MarginFCF / Revenue | 6.6% | — |
| Capex IntensityCapex / Revenue | 5.6% | — |
| Cash ConversionOCF / Net Profit | 7.04× | — |
| TTM Free Cash FlowTrailing 4 quarters | $32.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $56.3M | — | ||
| Q3 25 | $56.2M | — | ||
| Q2 25 | $-12.6M | $98.2M | ||
| Q1 25 | $14.9M | $41.1M | ||
| Q4 24 | $29.3M | $84.3M | ||
| Q3 24 | $54.5M | $63.9M | ||
| Q2 24 | $30.8M | $75.5M | ||
| Q1 24 | $-34.8M | $81.0M |
| Q4 25 | $30.3M | — | ||
| Q3 25 | $41.4M | — | ||
| Q2 25 | $-29.2M | $93.3M | ||
| Q1 25 | $-10.6M | $31.0M | ||
| Q4 24 | $-27.8M | $77.5M | ||
| Q3 24 | $21.0M | $54.7M | ||
| Q2 24 | $5.2M | $57.5M | ||
| Q1 24 | $-61.0M | $64.5M |
| Q4 25 | 6.6% | — | ||
| Q3 25 | 10.2% | — | ||
| Q2 25 | -7.2% | 29.4% | ||
| Q1 25 | -3.2% | 9.8% | ||
| Q4 24 | -6.5% | 26.1% | ||
| Q3 24 | 5.6% | 18.9% | ||
| Q2 24 | 1.4% | 18.8% | ||
| Q1 24 | -18.7% | 21.3% |
| Q4 25 | 5.6% | — | ||
| Q3 25 | 3.7% | — | ||
| Q2 25 | 4.1% | 1.5% | ||
| Q1 25 | 7.6% | 3.2% | ||
| Q4 24 | 13.4% | 2.3% | ||
| Q3 24 | 8.9% | 3.2% | ||
| Q2 24 | 6.8% | 5.9% | ||
| Q1 24 | 8.0% | 5.4% |
| Q4 25 | 7.04× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -1.32× | — | ||
| Q1 25 | 0.24× | 1.82× | ||
| Q4 24 | — | 2.42× | ||
| Q3 24 | — | 1.90× | ||
| Q2 24 | — | 1.86× | ||
| Q1 24 | — | 1.65× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CCO
Segment breakdown not available.
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
